Table 1.
Study participant characteristics (n=25)
| Participant Characteristic | N | % |
|---|---|---|
| Age | ||
| 18 – 25 | 12 | 48 |
| 26 – 40 | 13 | 52 |
| Race (% Caucasian) | 22 | 88 |
| High School Education or more | 21 | 84 |
| Insurance (% Medicaid) | 25 | 100 |
| Primiparous | 9 | 36 |
| Married or living with partner | 9 | 36 |
| Employed during pregnancy | 5 | 20 |
| Smoked during pregnancy | 19 | 76 |
| Timing of conversion to methadone | ||
| Before Pregnancy | 1 | 4 |
| 1st Trimester | 13 | 52 |
| 2nd Trimester | 7 | 28 |
| 3rd Trimester | 4 | 16 |
| Taking psychotropic medication | ||
| At enrollment (self report) | 4 | 16 |
| At delivery (medical record review; n=22) | 9 | 41 |
| Hepatitis C positive | 14 | 56 |
| Hepatitis B positive | 0 | -- |
| Drug Screen Positive for Illicit Drugs at Delivery (positive for benzodiazepines and opiates) |
1 | 4 |
| Edinburgh Postnatal Depression Scale ≥ 10 (3rd tri) | 20 | 80 |
| aMood Disorder Questionnaire33 | 4 | 16 |
| bPrimary Care PTSD Screen34 | 12 | 48 |
| Methadone Dose (mg/day) | Mean (sd) | Range |
| At Delivery | 102.6 (44.3) | 22-200 |
| Late Postpartum (n=22) | 105.9 (42.1) | 26-190 |
a
Positive if “yes” to seven or more of the 13 items in question number 1 and yes to question 2 and answers moderate or serious to question 3.
b
PTSD: post-traumatic stress disorder screen positive screen if patient answered “yes” to any two items or to item three (hyper-arousal).